Migralgin

Paracetamol, Acetylsalicylic Acid, Caffeine, the active ingredient in Migralgin, is a combination analgesic presented as a combination oral tablet for oral use. It treats headache, migraine, fever and mild to moderate pain in adults.

GNH USA supplies Migralgin as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Migralgin, a combination analgesic, relieves pain and fever by inhibiting prostaglandin synthesis and enhancing analgesic response.

Headache: provides rapid relief of tension‑type and migraine‑associated headache. Fever: lowers elevated body temperature in febrile conditions. Pain: alleviates mild to moderate musculoskeletal, dental or postoperative pain. Migraine: reduces intensity of migraine attacks when taken early. Dental pain: eases discomfort after dental procedures.

Adverse reactions may occur with Migralgin and are classified by frequency.

Common Side Effects: - Nausea or upset stomach - Heartburn or dyspepsia - Insomnia or nervousness - Dizziness or light‑headedness - Increased heart rate - Mild headache

Serious or Rare Side Effects: - Allergic reactions such as rash, swelling or anaphylaxis - Gastrointestinal bleeding or ulceration - Severe liver injury or hepatitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Thrombocytopenia or clotting disorders - Severe hypertension or cardiac arrhythmias

Before using Migralgin, consider the following safety measures.

Assess liver function: avoid in patients with severe hepatic impairment. Assess renal function: use cautiously in renal disease. Avoid in known aspirin allergy: risk of hypersensitivity reactions. Limit alcohol intake: increased risk of liver injury. Pregnancy and breastfeeding: consult a healthcare professional before use. Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Migralgin can interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Selective serotonin reuptake inhibitors: risk of bleeding. - Methotrexate: enhanced toxicity. - Lithium: increased serum lithium levels.

Moderate Interactions (Monitor Closely): - CYP1A2 inhibitors (e.g., fluoroquinolones): may raise caffeine levels. - Diuretics: possible reduced renal clearance of aspirin. - Alcohol: additive hepatotoxicity.